CID 168010351
Varlaxin 754
Structural Information
- Molecular Formula
- C30H54N6O14S
- SMILES
- CCC(C)C(C(=O)N1C2CC(CCC2CC1C(=O)NCCCCN=C(N)N)OC3C(C(C(C(O3)CO)O)O)O)NC(=O)C(COS(=O)(=O)O)OC
- InChI
- InChI=1S/C30H54N6O14S/c1-4-15(2)22(35-27(42)21(47-3)14-48-51(44,45)46)28(43)36-18-12-17(49-29-25(40)24(39)23(38)20(13-37)50-29)8-7-16(18)11-19(36)26(41)33-9-5-6-10-34-30(31)32/h15-25,29,37-40H,4-14H2,1-3H3,(H,33,41)(H,35,42)(H4,31,32,34)(H,44,45,46)
- InChIKey
- RAJLZDCTCSZRRK-UHFFFAOYSA-N
- Compound name
- [3-[[1-[2-[4-(diaminomethylideneamino)butylcarbamoyl]-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-2-methoxy-3-oxopropyl] hydrogen sulfate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 755.34914 | 258.6 |
[M+Na]+ | 777.33108 | 256.9 |
[M-H]- | 753.33458 | 256.7 |
[M+NH4]+ | 772.37568 | 259.1 |
[M+K]+ | 793.30502 | 258.3 |
[M+H-H2O]+ | 737.33912 | 242.8 |
[M+HCOO]- | 799.34006 | 260.1 |
[M+CH3COO]- | 813.35571 | 263.3 |
[M+Na-2H]- | 775.31653 | 285.7 |
[M]+ | 754.34131 | 276.6 |
[M]- | 754.34241 | 276.6 |
Literature stripe
Patent stripe
No patent data available for this compound.